13 September 2025 in Journal of the American Chemical Society
The use of molecular glues to modulate protein-protein interactions has emerged as a promising approach to drug previously intractable targets. Despite strong interest in this modality, a comprehensive theoretical framework is lacking. We have established a complete mechanistic analysis which enables the determination of molecular glues' binding and cooperativity values from a simple biochemical matrix experiment. We validated the model using numerical integration and experimental data from fluorescence resonance energy transfer and fluorescence polarization assays. As the derived models enable the determination of all thermodynamic parameters of any molecular glue, they have significant applications in drug discovery, particularly for molecular glue optimization and characterization of neo-substrates.
4 September 2025 in ACS Medicinal Chemistry Letters
30 March 2026 in ACS Chemical Biology
13 April 2026 in Journal of Chemical Information and Modeling
Molecular glues are small molecules that offer a powerful strategy to target previously "undruggable" proteins of interest (POI) by enhancing their interactions with other proteins (effectors). Depending on the nature of the effectors, molecular glues can induce stabilizing sequestration or degradation of the POI. However, their rational design has been hindered by a poor understanding of how kinetic parameters impact their performance. To address this, we developed a unified mathematical framework that accurately represents the dynamics of both glue degraders and stabilizers in both in vitro and cellular contexts. By analyzing our model, we determined the effects of varying specific kinetic parameters on the cellular-level performance of molecular glues. Our model suggests that the binding affinity of the ternary complex is the key determinant of performance across both modalities, provided that the initial component concentrations and degradation rate constants are fixed. Furthermore, we demonstrated that degrader performance is ultimately limited by its catalytic efficiency and the target protein's natural half-life. We also identified distinct roles for effector abundance, showing that the relative concentrations of the effector and POI are critical for stabilizers but less so for degraders. This quantitative framework provides mechanistic principles for the rational design and optimization of molecular glues.
27 March 2026 in ACS Chemical Biology
The E3 ligase βTrCP regulates a significant number of important cytosolic proteins by recognizing and binding to a “DSGXXS” consensus phosphodegron sequence, resulting in the ubiquitination and degradation of target proteins. While many of the substrates of βTrCP have strong disease links, there is high-resolution structural data available for just one of these proteins in complex with βTrCP. Here, we describe the development of a robust crystallographic system for βTrCP and report high-resolution crystal structures for βTrCP in complex with degrons from five new targets, encompassing the important cancer proteins, WEE1, claspin, ATF4, PDCD4, and IκBα. Interestingly, these structures reveal the molecular basis by which βTrCP can recognize and bind both consensus and nonconsensus degron peptides and reveal an overall general plasticity in degron binding mode. We also provide a biochemical assessment of the binding affinities of these peptides for βTrCP, adding further insight into the molecular interactions observed in the crystal structures. Finally, computational analyses of the βTrCP complexes identify opportunities for potential molecular glue approaches.